UBS Group’s Stoneridge SRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Sell
37,324
-220,071
-85% -$1.51M ﹤0.01% 6602
2026
Q1
$1.24M Buy
257,395
+78,809
+44% +$540K ﹤0.01% 5378
2025
Q4
$1.03M Buy
178,586
+49,326
+38% +$310K ﹤0.01% 5541
2025
Q3
$985K Buy
129,260
+73,818
+133% +$585K ﹤0.01% 5586
2025
Q2
$390K Buy
55,442
+23,314
+73% +$114K ﹤0.01% 6217
2025
Q1
$147K Sell
32,128
-20,191
-39% -$103K ﹤0.01% 6754
2024
Q4
$328K Buy
52,319
+6,657
+15% +$51.1K ﹤0.01% 6142
2024
Q3
$511K Buy
45,662
+11,904
+35% +$170K ﹤0.01% 5210
2024
Q2
$539K Sell
33,758
-1,963
-5% -$31.4K ﹤0.01% 4942
2024
Q1
$659K Buy
35,721
+2,600
+8% +$46.2K ﹤0.01% 4967
2023
Q4
$648K Buy
33,121
+14,490
+78% +$252K ﹤0.01% 4876
2023
Q3
$374K Sell
18,631
-140
-0.7% -$2.84K ﹤0.01% 4880
2023
Q2
$354K Buy
18,771
+7,786
+71% +$137K ﹤0.01% 5097
2023
Q1
$205K Sell
10,985
-902
-8% -$19.4K ﹤0.01% 5367
2022
Q4
$256K Buy
11,887
+11,451
+2,626% +$245K ﹤0.01% 5253
2022
Q3
$7K Sell
436
-161
-27% -$3.02K ﹤0.01% 8902
2022
Q2
$10K Sell
597
-5,018
-89% -$95.3K ﹤0.01% 7998
2022
Q1
$116K Sell
5,615
-5,452
-49% -$100K ﹤0.01% 5795
2021
Q4
$219K Buy
11,067
+10,793
+3,939% +$228K ﹤0.01% 5607
2021
Q3
$6K Sell
274
-9
-3% -$223 ﹤0.01% 8446
2021
Q2
$8K Sell
283
-6,482
-96% -$205K ﹤0.01% 8254
2021
Q1
$215K Sell
6,765
-4,158
-38% -$131K ﹤0.01% 5429
2020
Q4
$330K Buy
10,923
+10,329
+1,739% +$268K ﹤0.01% 4909
2020
Q3
$11K Sell
594
-704
-54% -$14.4K ﹤0.01% 6783
2020
Q2
$27K Sell
1,298
-432
-25% -$8.09K ﹤0.01% 6349
2020
Q1
$29K Sell
1,730
-29,862
-95% -$741K ﹤0.01% 6245
2019
Q4
$926K Buy
31,592
+11,010
+53% +$339K ﹤0.01% 4290
2019
Q3
$637K Buy
20,582
+15,147
+279% +$475K ﹤0.01% 4349
2019
Q2
$171K Buy
5,435
+4,825
+791% +$143K ﹤0.01% 5014
2019
Q1
$18K Sell
610
-10,763
-95% -$294K ﹤0.01% 6395
2018
Q4
$280K Sell
11,373
-9,312
-45% -$237K ﹤0.01% 4684
2018
Q3
$615K Sell
20,685
-2,922
-12% -$92.6K ﹤0.01% 4271
2018
Q2
$830K Buy
23,607
+12,667
+116% +$385K ﹤0.01% 3937
2018
Q1
$302K Buy
10,940
+8,807
+413% +$215K ﹤0.01% 4517
2017
Q4
$49K Sell
2,133
-2,439
-53% -$54.5K ﹤0.01% 5854
2017
Q3
$90K Buy
4,572
+3,734
+446% +$61.8K ﹤0.01% 5378
2017
Q2
$13K Buy
838
+32
+4% +$536 ﹤0.01% 6607
2017
Q1
$15K Sell
806
-3,359
-81% -$59.1K ﹤0.01% 6357
2016
Q4
$74K Buy
+4,165
New +$70.5K ﹤0.01% 5521
2016
Q1
Sell
-717
Closed -$11K 8134
2015
Q4
$11K Buy
+717
New +$9.64K ﹤0.01% 7237
2015
Q1
Sell
-1,226
Closed -$16K 9341
2014
Q4
$16K Buy
+1,226
New +$14.3K ﹤0.01% 7963

Other funds holding SRI

UBS Group's SRI Position: Q2 2026 in Review

UBS Group reduced its Stoneridge (SRI) stake by 85% in Q2 2026, selling an estimated $1.51M and leaving 37,324 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #6602.

UBS Group first reported a position in SRI in Q4 2014 and has held it in 41 quarters since. The position peaked at $1.24M in Q1 2026. 112 funds tracked by Wall St. Rank hold SRI as of Q2 2026.

  • UBS Group held 37,324 shares of Stoneridge worth $273K as of Q2 2026.
  • UBS Group sold 220,071 Stoneridge shares in Q2 2026, an estimated $1.51M.
  • Stoneridge made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6602 holding.
  • UBS Group first reported a position in Stoneridge in Q4 2014 and has held it in 41 quarters since.
  • UBS Group's Stoneridge position peaked at $1.24M in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Stoneridge as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.